Literature DB >> 32844295

Homostachydrine is a Xenobiotic Substrate of OCTN1/SLC22A4 and Potentially Sensitizes Pentylenetetrazole-Induced Seizures in Mice.

Misa Nishiyama1, Noritaka Nakamichi2,3, Tomoyuki Yoshimura1, Yusuke Masuo1, Tomoe Komori1, Takahiro Ishimoto1, Jun-Ichi Matsuo1, Yukio Kato1.   

Abstract

Understanding of the underlying mechanism of epilepsy is desired since some patients fail to control their seizures. The carnitine/organic cation transporter OCTN1/SLC22A4 is expressed in brain neurons and transports food-derived antioxidant ergothioneine (ERGO), L-carnitine, and spermine, all of which may be associated with epilepsy. This study aimed to clarify the possible association of this transporter with epileptic seizures. In both pentylenetetrazole (PTZ)-induced acute seizure and kindling models, ocnt1 gene knockout mice (octn1-/-) showed lower seizure scores compared with wild-type mice. Up-regulation of the epilepsy-related genes, c-fos and Arc, and the neurotrophic factor BDNF following PTZ administration was observed in the hippocampus of wild-type, but not octn1-/- mice. To find the OCTN1 substrate associated with the seizure, untargeted metabolomics analysis using liquid chromatography-quadrupole time-of-flight mass spectrometry was conducted on extracts from the hippocampus, frontal cortex, and plasma of both strains, leading to the identification of a plant alkaloid homostachydrine as a compound present in a lower concentration in octn1-/- mice. OCTN1-mediated uptake of deuterium-labeled homostachydrine was confirmed in OCTN1-transfected HEK293 cells, suggesting that this compound is a substrate of OCTN1. Homostachydrine administration increased PTZ-induced acute seizure scores and the expression of Arc in the hippocampus and that of Arc, Egr1, and BDNF in the frontal cortex. Conversely, administration of the OCTN1 substrate/inhibitor ERGO inhibited PTZ-induced kindling and reduced the plasma homostachydrine concentration. Thus, these results suggest that OCTN1 is at least partially associated with PTZ-induced seizures, which is potentially deteriorated by treatment with homostachydrine, a newly identified food-derived OCTN1 substrate.

Entities:  

Keywords:  Epilepsy; Ergothioneine; Metabolomics; Pentylenetetrazole; Seizure; Slc22a4

Mesh:

Substances:

Year:  2020        PMID: 32844295     DOI: 10.1007/s11064-020-03118-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

1.  SLC6A1 variants identified in epilepsy patients reduce γ-aminobutyric acid transport.

Authors:  Kari A Mattison; Kameryn M Butler; George Andrew S Inglis; Oshrat Dayan; Hanna Boussidan; Vikas Bhambhani; Bryan Philbrook; Cristina da Silva; John J Alexander; Baruch I Kanner; Andrew Escayg
Journal:  Epilepsia       Date:  2018-08-21       Impact factor: 5.864

Review 2.  Epilepsy-associated genes.

Authors:  Jie Wang; Zhi-Jian Lin; Liu Liu; Hai-Qing Xu; Yi-Wu Shi; Yong-Hong Yi; Na He; Wei-Ping Liao
Journal:  Seizure       Date:  2016-12-06       Impact factor: 3.184

3.  Discovery of the ergothioneine transporter.

Authors:  Dirk Gründemann; Stephanie Harlfinger; Stefan Golz; Andreas Geerts; Andreas Lazar; Reinhard Berkels; Norma Jung; Andrea Rubbert; Edgar Schömig
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

4.  Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1.

Authors:  Yukio Kato; Yoshiyuki Kubo; Daisuke Iwata; Sayaka Kato; Tomohisa Sudo; Tomoko Sugiura; Takashi Kagaya; Tomohiko Wakayama; Akiyoshi Hirayama; Masahiro Sugimoto; Kazushi Sugihara; Shuichi Kaneko; Tomoyoshi Soga; Masahide Asano; Masaru Tomita; Toshiyuki Matsui; Morimasa Wada; Akira Tsuji
Journal:  Pharm Res       Date:  2010-03-12       Impact factor: 4.200

5.  Molecular and functional characterization of organic cation/carnitine transporter family in mice.

Authors:  I Tamai; R Ohashi; J I Nezu; Y Sai; D Kobayashi; A Oku; M Shimane; A Tsuji
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

Review 6.  The glucose transporter type 1 (Glut1) syndromes.

Authors:  Henner Koch; Yvonne G Weber
Journal:  Epilepsy Behav       Date:  2018-07-31       Impact factor: 2.937

7.  Combination Metabolomics Approach for Identifying Endogenous Substrates of Carnitine/Organic Cation Transporter OCTN1.

Authors:  Yusuke Masuo; Yuri Ohba; Kohei Yamada; Aya Hasan Al-Shammari; Natsumi Seba; Noritaka Nakamichi; Takuo Ogihara; Munetaka Kunishima; Yukio Kato
Journal:  Pharm Res       Date:  2018-10-02       Impact factor: 4.200

8.  Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: gain-of-function by interchange of selected amino acids.

Authors:  Petra Bacher; Susanne Giersiefer; Markus Bach; Christian Fork; Edgar Schömig; Dirk Gründemann
Journal:  Biochim Biophys Acta       Date:  2009-10-06

9.  Organic cation transporter-mediated ergothioneine uptake in mouse neural progenitor cells suppresses proliferation and promotes differentiation into neurons.

Authors:  Takahiro Ishimoto; Noritaka Nakamichi; Hiroshi Hosotani; Yusuke Masuo; Tomoko Sugiura; Yukio Kato
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

10.  Effects of Vitamin E on seizure frequency, electroencephalogram findings, and oxidative stress status of refractory epileptic patients.

Authors:  Jafar Mehvari; Fataneh Gholami Motlagh; Mohamad Najafi; Mohammad Reza Aghaye Ghazvini; Amirmansour Alavi Naeini; Mohamad Zare
Journal:  Adv Biomed Res       Date:  2016-03-16
View more
  3 in total

Review 1.  Ergothioneine and central nervous system diseases.

Authors:  Noritaka Nakamichi; Sota Tsuzuku; Fumiya Shibagaki
Journal:  Neurochem Res       Date:  2022-07-05       Impact factor: 4.414

2.  Emerging Roles of the Human Solute Carrier 22 Family.

Authors:  Sook Wah Yee; Kathleen M Giacomini
Journal:  Drug Metab Dispos       Date:  2021-12-17       Impact factor: 3.579

Review 3.  OCTN1: A Widely Studied but Still Enigmatic Organic Cation Transporter Linked to Human Pathology and Drug Interactions.

Authors:  Lorena Pochini; Michele Galluccio; Mariafrancesca Scalise; Lara Console; Gilda Pappacoda; Cesare Indiveri
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.